Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 2, 2013, Pages 378-384

  Liauw, Stanley L ^a   Pitroda, Sean P ^a   Eggener, Scott E ^a   Stadler, Walter M ^a   Pelizzari, Charles A ^a   Vannier, Michael W ^a   Oto, Aytek ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL FAILURE; DYNAMIC CONTRAST-ENHANCED IMAGING; INTER QUARTILE RANGES; LOCAL RECURRENCE; PROGNOSTIC VARIABLES; PROSTATE SPECIFIC ANTIGEN; RADICAL PROSTATECTOMY; RISK FACTORS; TUMOR VOLUMES;

MAGNETIC RESONANCE IMAGING;

UROLOGY;

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; ENDORECTAL NUCLEAR MAGNETIC RESONANCE IMAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIODIAGNOSIS; SALVAGE THERAPY; TREATMENT FAILURE; TUMOR VOLUME;

AGED; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PATIENT SELECTION; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY;

EID: 84872190137     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.05.015     Document Type: Article

References (18)

1. E.S. Antonarakis, Z. Feng, and B.J. Trock The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up BJU Int 109 2012 32 39
2. B.J. Trock, M. Han, and S.J. Freedland Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy JAMA 299 2008 2760 2769
3. S.E. Cotter, M.H. Chen, and J.W. Moul Salvage radiation in men after prostate-specific antigen failure and the risk of death Cancer 117 2011 3925 3932
4. C.J. Kane, C.L. Amling, and P.A. Johnstone Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy Urology 61 2003 607 611
5. S.L. Liauw, R.R. Weichselbaum, and G.P. Zagaja Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease? Int J Radiat Oncol Biol Phys 71 2008 1316 1321
6. H. Jadvar Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline J Nucl Med 52 2011 81 89
7. T. Sella, L.H. Schwartz, and P.W. Swindle Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging Radiology 231 2004 379 385
8. E. Casciani, E. Polettini, and E. Carmenini Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy AJR Am J Roentgenol 190 2008 1187 1192
9. R. Miralbell, H. Vees, and J. Lozano Endorectal MRI assessment of local relapse after surgery for prostate cancer: a model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure Int J Radiat Oncol Biol Phys 67 2007 356 361
10. H. Vees, F. Buchegger, and S. Albrecht 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy BJU Int 99 2007 1415 1420
11. C.R. King Adjuvant radiotherapy after prostatectomy: does waiting for a detectable prostate-specific antigen level make sense? Int J Radiat Oncol Biol Phys 80 2011 1 3
12. T. Sella, L.H. Schwartz, and H. Hricak Retained seminal vesicles after radical prostatectomy: frequency, MRI characteristics, and clinical relevance AJR Am J Roentgenol 186 2006 539 546
13. T. Wiegel, D. Bottke, and U. Steiner Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 2924 2930
14. A.J. Stephenson, P.T. Scardino, and M.W. Kattan Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2007 2035 2041
15. C.R. King, and M.T. Spiotto Improved outcomes with higher doses for salvage radiotherapy after prostatectomy Int J Radiat Oncol Biol Phys 71 2008 23 27
16. J. Sefrova, K. Odrazka, and P. Paluska Magnetic resonance imaging in postprostatectomy radiotherapy planning Int J Radiat Oncol Biol Phys 82 2012 911 918
17. K.L. Wiltshire, K.K. Brock, and M.A. Haider Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy Int J Radiat Oncol Biol Phys 69 2007 1090 1099
18. M.G. Schouten, J.G. Bomers, and D. Yakar Evaluation of a robotic technique for transrectal MRI-guided prostate biopsies Eur Radiol 22 2012 476 483